INFERTILITY DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Infertility Devices Market Size and Forecast – 2026 to 2033

Infertility Devices Market is estimated to be valued at USD 13,034.6 Mn in 2026 and is expected to reach USD 23,675.1 Mn in 2033, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.

Key Takeaways

• According to product type, the Equipment category is anticipated to account for the largest share of 66% for the Infertility Devices market in 2026.  
• According to region, North America holds 45.1% market share for Infertility Devices market growth by 2026.

Market Overview

The Infertility Devices Market Size is boosting rapidly due to factors such as growing infertility rates, advances in technology, and growing demand for and awareness of reproductive treatments. Rising incidence of infertility, improvements in human reproductive technologies, and growing awareness and accessibility of fertility treatments globally are all contributing to the market for infertility devices. With major competitors seeking acquisitions and strategic alliances to broaden their product lines and geographic reach, the market is somewhat consolidated.

Current Events and Its Impact on the Infertility Devices Market

Segmental Insights

Infertility Devices Market Insights, by Product Type

In terms of product type, the equipment segment is expected to contribute largest share of 66% for the Infertility Devices market trends in 2026. Sperm analyzers are part of the equipment segment, which is a sizable and quickly expanding segment of the global market for infertility technologies. 

In order to diagnose male infertility and guide assisted reproductive technologies (ART) like IVF and artificial insemination, sperm analyzer systems are specialized machines that evaluate a variety of sperm parameters, including count, motility, morphology, and viability.

Infertility Devices Market Insights, by Procedures

In terms of procedures, the assisted reproductive technology segment is expected to contribute largest share of the Infertility Devices market trends in 2026. The IVF technology sector, in particular, has the most market share for ART because of its high success rates and wide range of applications in treating different reasons of infertility.  Advancements include preimplantation genetic screening, embryo freezing, and time-lapse imaging have further solidified IVF's position as the industry leader.

Infertility Devices Market Insights, by Gender

In terms of gender, the female segment is expected to contribute largest share of the Infertility Devices market trends in 2026. Due to variables including obesity, poor lifestyles, and conditions like PCOS and PCOD, infertility is more common in women than in males.  As a result, there is now more demand for infertility drugs and technology made especially for women.

Infertility Devices Market Insights, by End User

In terms of end user, the fertility centers segment is expected to contribute largest share of the Infertility Devices market trends in 2026. The need for cutting-edge equipment and technologies in reproductive clinics is rising as a result of rising knowledge of fertility treatments and an increase in the number of couples seeking specialist care for infertility.

Regional Insights

North America Infertility Devices Market

North America has historically been the dominant region as it drives major Infertility Devices Market Trends. North America is at the forefront of technological advancements in infertility devices. For instance, CooperSurgical, a U.S.-based company, launched the PristineTM, a next-generation in-vitro fertilization (IVF) workstation that enhances the efficiency and success rates of IVF procedures.

Asia Pacific Infertility Devices Market

The increasing prevalence of infertility in the Asia Pacific region is driving the demand for infertility devices. According to a study by the Indian Society of Assisted Reproduction, infertility affects around 10-15% of the Indian population, which is approximately 27.5 million couples.

There is a growing awareness and acceptance of ART procedures such as in-vitro fertilization (IVF) and intrauterine insemination (IUI) in the Asia Pacific region. For example, in Japan, the number of ART cycles performed increased from 326,426 in 2010 to 447,790 in 2015, as reported by the Japan Society of Obstetrics and Gynecology.

Infertility Devices Market in Europe

The growing prevalence of infertility in Europe is a major driver for the market. A study published in the Human Reproduction Update journal in 2020 estimated that the prevalence of infertility in Europe ranges from 5.5% to 12.5% among women aged 20-44 years. Europe is known for its early adoption of advanced infertility treatment technologies.

Infertility Devices Market Dominating Countries

U.S Infertility Devices Market

Growth is fueled by the rising mean age of new mothers, improved diagnostic tools, and technological advancements in assisted reproductive technologies (ART), such as IVF and embryo cryopreservation. The presence of leading fertility clinics and device manufacturers, as well as continuous innovation in diagnostic and treatment devices, further strengthens the U.S. market’s dominance.   

India Infertility Devices Market

India is emerging as a significant player in the infertility devices market, propelled by rising infertility rates, greater awareness, and improved access to fertility treatments. Factors such as changing lifestyles, delayed parenthood, and increased prevalence of conditions like polycystic ovary syndrome (PCOS) contribute to the growing demand for infertility solutions.    

Infertility Devices Market in China

China holds a dominant position in the Asia-Pacific infertility devices market, supported by a large population base, rising infertility rates, and strong government focus on healthcare modernization. The country has seen substantial investments in reproductive technology and the expansion of fertility clinics, particularly in urban centers.

Market Report Scope

Infertility Devices Market: Growth Drivers

• Increasing inorganic strategies by key players  

Increasing inorganic strategies such as acquisition by the key market players is expected to drive the infertility devices market growth over the forecast period. For instance, in December 2021, Cooper Companies Inc., a medical device company signed an agreement to acquire Generate Life Sciences, a leading provider of donor egg and sperm for fertility treatments, for fertility cryopreservation services and newborn stem cell storage (cord blood & cord tissue).

Infertility Devices Market: Trends

• Increasing inorganic strategies by the key market players to drive the infertility devices market growth over the forecast period

For instance, in February 2022, Cooper Companies Inc., a medical device company, announced that had signed a binding letter of intent to acquire Cook Medical’s Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets. 

Infertility Devices Market: Opportunities

The development of novel, minimally invasive infertility devices and the integration of digital health technologies, such as artificial intelligence in fertility diagnostics and monitoring, are creating new opportunities. These innovations improve treatment outcomes, patient comfort, and accessibility, making advanced infertility care more widely available.

Increasing infertility rates globally, driven by lifestyle changes, delayed parenthood, and environmental factors, are fueling demand for infertility treatments and devices. Greater awareness and acceptance of assisted reproductive technologies (ART) like IVF, IUI, and gamete cryopreservation are also expanding the market’s reach.

Infertility Devices Market: Key Developments

• March 2025, IVF is an expensive process with no guarantees of it working for couples struggling with infertility. Now, there’s a company called Future Family that’s launching a new nationwide insurance policy to cover some of the expenses. Reporting for TODAY, NBC’s Vicky Nguyen shares details of the plan.
• December 2024, Kottakkal Arya Vaidya Sala launched two special clinics for gynaecological treatment and infertility treatment. The gynaecology clinic was named Arya women’s clinic and the other Bliss infertility clinic.
• July 2024, Nikon Corporation (Nikon) unveiled ECLIPSE Ti2-I Motorized Inverted Microscope for ICSI*3/IMSI*4, specialized for use in micro-insemination. By allowing the microscope settings to be automatically controlled via simple buttons and a touch screen close to your hands - we’ve improved efficiency by reducing the steps required for operation by approximately 75%. An alert function and bright, clear field of view support accurate operation.

Analyst Opinion

• Increasing inorganic strategies such as acquisition by key market players is expected to drive the infertility devices market growth over the forecast period. For instance, in July 2021, Vitrolife AB, an Invitro Fertilization (IVF) company, entered into a definitive agreement to acquire 100%of the shares in Igenomix S.L., a medical testing laboratory specializing in reproductive genetic services.
• The acquisition will create a global leader in reproductive health by combining the knowledge, product portfolios and market presence of two leading companies within IVF medical devices and reproductive genetic testing services.

Market Segmentation

• Global Infertility Devices Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
• Equipment
• Imaging Systems
• Sperm Analyzer Systems
• Ovum Aspiration Pumps
• Micromanipulators Systems
• Incubators
• Gas Analyzers
• Laser Systems
• Cryosystems
• Accessories
• Global Infertility Devices Market, By Procedure (Revenue, USD Mn, 2021 - 2033)
• Assisted Reproductive Technology
• Artificial Insemination
• Fertility Surgery
• Others
• Global Infertility Devices Market, By Gender (Revenue, USD Mn, 2021 - 2033)
• Male
• Female
• Global Infertility Devices Market, By End User (Revenue, USD Mn, 2021 - 2033)
• Fertility Centers
• Hospitals & Surgical Hospitals & Surgical Clinics
• Cryobanks
• Others
• Global Infertility Devices Market, By Region (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Company Profiles
• Thermo Fisher Scientific Inc.
• Vitrolife AB, The Baker Company, Inc.
• The Cooper Companies, Inc.
• Fujifilm Irvine Scientific
• IVFTECH APS
• Kitazato Corporation
• MedGyn Products, Inc.
• Rocket Medical plc
• SOMATEX Medical Technologies GmbH
• Cook Group Incorporated
• Esco Micro Pte Ltd
• Hamilton Thorne, Ltd
• Art Biotech Pvt. LTD, Merck

Sources

Primary Research interviews

• Fertility clinic directors
• IVF laboratory managers
• Obstetricians and gynecologists
• Reproductive endocrinologists
• Embryologists

Databases

• WHO Global Health Observatory
• UN Population Division
• World Bank Open Data
• National Health and Family Planning Commission (China)
• Centers for Disease Control and Prevention (CDC) – ART data

Magazines

• Medical Device + Diagnostic Industry (MD+DI)
• Fertility Road Magazine
• MedTech Insight
• BioSpectrum
• Healthcare Business International

Journals

• Fertility and Sterility
• Human Reproduction
• Journal of Assisted Reproduction and Genetics
• Reproductive Biology and Endocrinology
• The Lancet Reproductive Health

Newspapers

• Financial Times
• The Economic Times
• Business Standard
• Bloomberg
• STAT News

Associations

• American Society for Reproductive Medicine (ASRM)
• European Society of Human Reproduction and Embryology (ESHRE)
• Indian Society for Assisted Reproduction (ISAR)
• International Federation of Fertility Societies (IFFS)
• International Federation of Gynecology and Obstetrics (FIGO)
• Asia Pacific Initiative on Reproduction (ASPIRE)

Proprietary Elements

• CMI Data Analytics Tool, Proprietary CMI Existing Repository of information for last 8 year

*Definition  Infertility is a disease of the male or female reproductive system defined by the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse. Infertility affects millions of people – and has an impact on their families and communities. Estimates suggest that approximately one in every six people of reproductive age worldwide experience infertility in their lifetime.